Your browser doesn't support javascript.
loading
Development of BET inhibitors as potential treatments for cancer: A search for structural diversity.
Hill, Matthew D; Fang, Haiquan; Tokarski, John; Fanslau, Carolynn; Haarhoff, Zuzana; Huang, Christine; Kramer, Melissa; Menard, Krista; Monereau, Laura; Morrison, John; Ranasinghe, Asoka; Shields, Eric E; Tye, Ching Kim; Westhouse, Richard; Everlof, Gerry; Sheriff, Steven; Yan, Chunhong; Marsilio, Frank; Zhang, Lisa; Zvyaga, Tatyana; Lee, Francis; Gavai, Ashvinikumar V; Degnan, Andrew P.
Afiliação
  • Hill MD; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA. Electronic address: matthew.hill@bms.com.
  • Fang H; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Tokarski J; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Fanslau C; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Haarhoff Z; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Huang C; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Kramer M; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Menard K; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Monereau L; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Morrison J; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Ranasinghe A; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Shields EE; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Tye CK; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Westhouse R; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Everlof G; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Sheriff S; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Yan C; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Marsilio F; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Zhang L; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Zvyaga T; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Lee F; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Gavai AV; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Degnan AP; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
Bioorg Med Chem Lett ; 44: 128108, 2021 07 15.
Article em En | MEDLINE | ID: mdl-33991625
ABSTRACT
We describe our efforts to identify structurally diverse leads in the triazole-containing N1-carboline series of bromodomain and extra-terminal inhibitors. Replacement of the N5 "cap" phenyl moiety with various heteroaryls, coupled with additional modifications to the carboline core, provided analogs with similar potency, improved pharmacokinetic properties, and increased solubility compared to our backup lead, BMS-986225 (2). Rapid SAR exploration was enabled by a convergent, synthetic route. These efforts provided a potent BET inhibitor, 3-fluoropyridyl 12, that demonstrated robust efficacy in a multiple myeloma mouse tumor model at 1 mg/kg.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazóis / Carbolinas / Proteínas / Desenvolvimento de Medicamentos / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazóis / Carbolinas / Proteínas / Desenvolvimento de Medicamentos / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2021 Tipo de documento: Article